Rizvi Qasim 4
4 · Kiniksa Pharmaceuticals, Ltd. · Filed Dec 16, 2019
Insider Transaction Report
Form 4
Rizvi Qasim
Chief Commercial Officer
Transactions
- Award
Restricted Share Units
2019-12-12+7,337→ 7,337 total→ Class A Common Shares (7,337 underlying)
Footnotes (2)
- [F1]Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.
- [F2]The Restricted Share Units will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date.